Pioneering Pulsed Field Ablation (PFA) with powerful clinical proof.
FARAPULSE PFA is the most studied pulsed field ablation technology, with unmatched data from pivotal trials and real-world registries.
Explore the research.
FARAPULSE PFA achieved robust safety and efficacy outcomes in both paroxysmal and persistent AFib populations.
ADVANTAGE AF US IDE Trial (Phase II)
Excellent performance that lowered atrial arrhythmia burden and healthcare utilization.
Pivotal trial evaluating the safety and effectiveness of FARAPULSE PFA in the treatment of drug-refractory persistent atrial fibrillation.
SINGLE SHOT CHAMPION Trial
Superior reductions in recurrence.
First large, randomized clinical trial directly comparing the safety and effectiveness of FARAPULSE PFA versus Medtronic Arctic Front Advance Cryoballoon to treat symptomatic paroxysmal atrial fibrillation using continuous rhythm monitoring.
MANIFEST-17K Multicenter Registry
Low rate of safety events in real-world patient safety registry.
Multinational survey on the safety of the post-approval clinical use of pulsed field ablation in 17,000+ patients with paroxysmal atrial fibrillation.
ADVENT US IDE Trial
Outstanding performance comparable to thermal ablation.
First randomized clinical trial directly comparing FARAPULSE PFA to standard-of-care thermal ablation devices (force-sensing radiofrequency or cryoballoon ablation) in the treatment of paroxysmal atrial fibrillation.
Helpful resources
Get a detailed clinical overview of FARAPULSE PFA.
Connect with us for additional information.
Locate centers performing the FARAPULSE PFA procedure.